Literature DB >> 21084992

An additive effect of protective host genetic factors correlates with HIV nonprogression status.

María Salgado1, Ainhoa Simón, Beatriz Sanz-Minguela, Norma Ibón Rallón, Mariola López, José Luis Vicario, José Miguel Benito, Berta Rodés.   

Abstract

INTRODUCTION: In HIV-positive individuals, complex multifactorial mechanisms control viral infection. In addition to viral and immunological factors, the host genetic background also plays an important role. Our objective was to evaluate how various genetic factors associated with delayed AIDS onset.
METHODS: Thirty HIV+ long-term nonprogressors (LTNPs) and 30 known progressors were analyzed. Host genes were analyzed in peripheral blood mononuclear cells DNA: CCR5 and HLA were polymerase chain reaction typed. HLA-C5', HCP5 polymorphisms, and CCL3L1 copy number were determined using real-time polymerase chain reaction.
RESULTS: The CCL3L1high-copy-CCR5 deletion genetic risk groups was overrepresented in LTNPs. However, separately, neither CCL3L1 nor CCR5 were significantly associated with clinical outcome. HLA seemed as a strong nonprogression determinant, mainly HLA-B and the less-studied HLA-C. HLA-Cw0102 and HLA-C5' had an impact on LTNP phenotype along with HLA-B5701 and B2705. The presence of allele combinations like HLA- B*5701-Cw0602, HLA-B*2705-Cw0102, or HLA-B*3801-Cw1203 had the strongest effect in non-progression. As for HCP5, no independent effect was observed. The studied factors had additive effects, and although the number of patients was small, it seemed that carrying a high number of protective alleles associated with progression delay.
CONCLUSIONS: We showed the additive load of protective host factors was predictive of nonprogression, and that HLA-associated factors were predominant in this global effect.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21084992     DOI: 10.1097/QAI.0b013e3182036f14

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  13 in total

1.  HLA alleles are associated with altered risk for disease progression and central nervous system impairment of HIV-infected children.

Authors:  Kumud K Singh; Ping Kathryn Gray; Yan Wang; Terence Fenton; Rodney N Trout; Stephen A Spector
Journal:  J Acquir Immune Defic Syndr       Date:  2011-05-01       Impact factor: 3.731

2.  Mauritian cynomolgus macaques with M3M4 MHC genotype control SIVmac251 infection.

Authors:  Hongzhao Li; Robert W Omange; Chris Czarnecki; Jorge F Correia-Pinto; Jose Crecente-Campo; Meika Richmond; Lin Li; Nancy Schultz-Darken; Maria J Alonso; James B Whitney; Francis A Plummer; Ma Luo
Journal:  J Med Primatol       Date:  2017-08       Impact factor: 0.667

3.  Enhanced Recognition of HIV-1 Cryptic Epitopes Restricted by HLA Class I Alleles Associated With a Favorable Clinical Outcome.

Authors:  Anju Bansal; Tiffanie Mann; Sarah Sterrett; Binghao J Peng; Anne Bet; Jonathan M Carlson; Paul A Goepfert
Journal:  J Acquir Immune Defic Syndr       Date:  2015-09-01       Impact factor: 3.731

4.  CCL3L1 gene copy number in individuals with and without HIV-associated neurocognitive disorder.

Authors:  Amanda Brown; Ned Sacktor; Karen Marder; Bruce Cohen; Giovanni Schifitto; Richard L Skolasky; Jason Creighton; Liping Guo; Justin C McArthur
Journal:  Curr Biomark Find       Date:  2012-01-01

5.  Implications of the incidentalome for clinical pharmacogenomics.

Authors:  Kyle B Brothers; Martin Langanke; Pia Erdmann
Journal:  Pharmacogenomics       Date:  2013-08       Impact factor: 2.533

6.  The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infection.

Authors:  Jason S Reed; John Sidney; Shari M Piaskowski; Chrystal E Glidden; Enrique J León; Benjamin J Burwitz; Holly L Kolar; Christopher M Eernisse; Jessica R Furlott; Nicholas J Maness; Andrew D Walsh; Richard A Rudersdorf; Wilfried Bardet; Curtis P McMurtrey; David H O'Connor; William H Hildebrand; Alessandro Sette; David I Watkins; Nancy A Wilson
Journal:  Immunogenetics       Date:  2011-07-06       Impact factor: 3.330

7.  Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load.

Authors:  Luca Genovese; Manuela Nebuloni; Massimo Alfano
Journal:  Front Immunol       Date:  2013-04-09       Impact factor: 7.561

Review 8.  HLA-C and HIV-1: friends or foes?

Authors:  Donato Zipeto; Alberto Beretta
Journal:  Retrovirology       Date:  2012-05-09       Impact factor: 4.602

9.  HIV-infected sex workers with beneficial HLA-variants are potential hubs for selection of HIV-1 recombinants that may affect disease progression.

Authors:  Chih-Hao Chang; Nicolaas C Kist; Tammy L Stuart Chester; Vattipally B Sreenu; Melissa Herman; Ma Luo; Daniel Lunn; John Bell; Francis A Plummer; T Blake Ball; Aris Katzourakis; Astrid K N Iversen
Journal:  Sci Rep       Date:  2015-06-17       Impact factor: 4.379

10.  HLA B*5701 status, disease progression, and response to antiretroviral therapy.

Authors: 
Journal:  AIDS       Date:  2013-10-23       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.